Add to favorites

#Industry News

EKF secures FDA clearance for DiaSpect Tm POC hemoglobin analyzer

Easy to use, reagent-free analyzer cleared for use in POC & CLIA waived settings

EKF Diagnostics announces U.S. Food and Drug Administration (FDA) 510(k) clearance and CLIA waiver for the Company’s hand-held, reagent-free hemoglobin analyzer, the DiaSpect Tm. The device is cleared for use in point of care (POC) and Certificate of Waiver settings, such as physicians’ offices, clinics and other non-traditional laboratory locations.

EKF secures FDA clearance for DiaSpect Tm POC hemoglobin analyzer

Details

  • Avon House, 19 Stanwell Rd, Penarth CF64 2EZ, UK
  • Martyn Lewis

    Keywords